According to filings with the U.S. Securities and Exchange Commission, SiPhox is raising $15,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Diedrik Vermeulen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About SiPhox
SiPhox was founded by Diedrik Vermeulen and Michael Dubrovsky one month BC (before Covid) in 2020. SiPhoxs mission is to build a next-generation biosensing platform that provides the power of several large laboratory instruments in a handheld device that accepts disposable cartridges. Each cartridge can multiplex many biomarkers on a single $0.50 silicon photonic chip and provides highly sensitive readout of immunoassays and RNA/DNA. The SiPhox team has extensive experience translating cutting-edge optical chip technology into mass produced products used all over the world, and is bringing the same proven approach to the next frontier for integrated photonics: biology.

To learn more about SiPhox, visit http://www.siphox.bio/

Contact:
Diedrik Vermeulen, Chief Executive Officer
732-861-1305
https://www.linkedin.com/in/diedrik-vermeulen-a32361a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.